Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Dr. Martens Plc ( (GB:DOCS) ) has provided an announcement.
Dr. Martens Plc announced that its total issued ordinary share capital consists of 966,407,209 shares, each carrying one voting right. This information is crucial for shareholders to determine their notification requirements under the FCA’s rules, impacting how they manage their interests in the company.
The most recent analyst rating on (GB:DOCS) stock is a Hold with a £86.00 price target. To see the full list of analyst forecasts on Dr. Martens Plc stock, see the GB:DOCS Stock Forecast page.
Spark’s Take on GB:DOCS Stock
According to Spark, TipRanks’ AI Analyst, GB:DOCS is a Neutral.
Dr. Martens Plc’s overall stock score is driven by stable financial performance with strong cash flow but declining revenue and profitability. Technical indicators show mixed momentum, while the high P/E ratio suggests overvaluation. The earnings call provided a balanced view with significant achievements in debt reduction and cost savings, but challenges remain in revenue growth and margin improvement.
To see Spark’s full report on GB:DOCS stock, click here.
More about Dr. Martens Plc
Dr. Martens Plc is a company operating in the footwear industry, known for its iconic boots and shoes. It focuses on producing durable and stylish footwear that appeals to a broad market, including fashion enthusiasts and those seeking practical, long-lasting shoes.
Average Trading Volume: 1,268,107
Technical Sentiment Signal: Hold
Current Market Cap: £943.6M
Find detailed analytics on DOCS stock on TipRanks’ Stock Analysis page.